Warning letterFDA · Jan 22, 2026
Diamond-Herpanacine of PA, Inc. MARCS-CMS 713854, January 22, 2026
Named company: Diamond-Herpanacine of PA, Inc.
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Diamond Eye Health and Herpanacine Skin…
Lot information: not specified in this record.